Volume 8, Issue 25 (12-2001)                   RJMS 2001, 8(25): 334-338 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nazifii A. EFFECT OF OMEPRAZOLE PLUS CIPROFLOXACIN ON HEALING OF DUODENAL ULCER AND ERADICATION OF HELICOBACTER PYLORI. RJMS 2001; 8 (25) :334-338
URL: http://rjms.iums.ac.ir/article-1-352-en.html
Abstract:   (63129 Views)

 Recently the Combined Therapy of omeprazole (O) a powerful anti ulcer drag with antibiotic has been studied in patients with helicobacter pyloi (HP) associated duodenal ulcer (DU). The efficacy of (O) plus ciprofloxacin (C) Therapy on healing of Du and eradication of HP was tested in a randomized, double-blind, placebo controlled prospective study. Eighty four patients with HP positive Du disease were randomly assigned to receive O 20 mg (28 days) plus C 250 mg bid (7 days) or placebo. The patients were devided in to following four groups.

 Group 1 (O+C n=22)

 Group 2 (O placebo +C placebo n=22)

 Group 3 (O placebo +C n=19)

 Group 4 (O+C placebo n=21)

  Endoscopy and two biopsies from antrum for rapid urease test and histology were performed in all patients at the entry and three to seven days after the end of the therapy.

  Du healing rates were 88% in group 1, 13% in group 2, 24% in group 3, and 78% in group 4, the proportions of Hp negativity were 65% in group 1, 13% in group 2, 19% in group 3, and 24% in group 4. The highest rates of ulcer healing or Hp eradication were observed in group 1 receiving O+C.

  1- Omeprazole is a safe and effective drug for short termulcer therapy in patients with Du disease.

  2- Omeprazole plus ciprofloxacin therapy is highly effective concerning Hp eradication.

  3- Du healing rate with o plus c Therapy may be increased as compared to omeprazole therapy olane.

Full-Text [PDF 229 kb]   (59467 Downloads)    
Type of Study: Research |

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC-SA 4.0 | Razi Journal of Medical Sciences

Designed & Developed by : Yektaweb